DNA
Ginkgo Bioworks·NYSE
--
--(--)
--
--(--)
7.09 / 10
Outperform
DNA's fundamental score of 7.09/10 reflects a solid condition, with key positives including PB-ROE, Asset-MV, Revenue-MV, Profit-MV, and Cash-MV all contributing constructively. The Gross profit margin stands at an impressive 70.99%, and Net profit / Total profit is nearly 100%, underscoring operational efficiency. However, the Current assets turnover ratio and Fixed assets turnover ratio are below par, suggesting room for improvement in asset utilization. Overall, the fundamentals provide a sturdy base but are not without weaknesses.
Analysis Checks(8/10)
Revenue-MV
Value-1.14
Score3/3
Weight34.34%
1M Return20.82%
Value-1.14
Score3/3
Weight34.34%
1M Return20.82%
Gross profit margin (%)
Value70.99
Score2/3
Weight1.65%
1M Return1.47%
Value70.99
Score2/3
Weight1.65%
1M Return1.47%
PB-ROE
Value-0.34
Score3/3
Weight15.68%
1M Return11.47%
Value-0.34
Score3/3
Weight15.68%
1M Return11.47%
Fixed assets turnover ratio
Value0.72
Score1/3
Weight-1.58%
1M Return-1.64%
Value0.72
Score1/3
Weight-1.58%
1M Return-1.64%
Cash-MV
Value-0.07
Score2/3
Weight10.00%
1M Return7.73%
Value-0.07
Score2/3
Weight10.00%
1M Return7.73%
Inventory turnover ratio
Value47.85
Score3/3
Weight5.86%
1M Return5.26%
Value47.85
Score3/3
Weight5.86%
1M Return5.26%
Profit-MV
Value0.46
Score2/3
Weight9.98%
1M Return7.79%
Value0.46
Score2/3
Weight9.98%
1M Return7.79%
Current assets turnover ratio
Value0.25
Score1/3
Weight-0.50%
1M Return-0.48%
Value0.25
Score1/3
Weight-0.50%
1M Return-0.48%
Asset-MV
Value-0.50
Score3/3
Weight23.17%
1M Return14.99%
Value-0.50
Score3/3
Weight23.17%
1M Return14.99%
Net profit / Total profit (%)
Value99.92
Score2/3
Weight1.41%
1M Return1.28%
Value99.92
Score2/3
Weight1.41%
1M Return1.28%
Revenue-MV
Value-1.14
Score3/3
Weight34.34%
1M Return20.82%
Value-1.14
Score3/3
Weight34.34%
1M Return20.82%
Inventory turnover ratio
Value47.85
Score3/3
Weight5.86%
1M Return5.26%
Value47.85
Score3/3
Weight5.86%
1M Return5.26%
Gross profit margin (%)
Value70.99
Score2/3
Weight1.65%
1M Return1.47%
Value70.99
Score2/3
Weight1.65%
1M Return1.47%
Profit-MV
Value0.46
Score2/3
Weight9.98%
1M Return7.79%
Value0.46
Score2/3
Weight9.98%
1M Return7.79%
PB-ROE
Value-0.34
Score3/3
Weight15.68%
1M Return11.47%
Value-0.34
Score3/3
Weight15.68%
1M Return11.47%
Current assets turnover ratio
Value0.25
Score1/3
Weight-0.50%
1M Return-0.48%
Value0.25
Score1/3
Weight-0.50%
1M Return-0.48%
Fixed assets turnover ratio
Value0.72
Score1/3
Weight-1.58%
1M Return-1.64%
Value0.72
Score1/3
Weight-1.58%
1M Return-1.64%
Asset-MV
Value-0.50
Score3/3
Weight23.17%
1M Return14.99%
Value-0.50
Score3/3
Weight23.17%
1M Return14.99%
Cash-MV
Value-0.07
Score2/3
Weight10.00%
1M Return7.73%
Value-0.07
Score2/3
Weight10.00%
1M Return7.73%
Net profit / Total profit (%)
Value99.92
Score2/3
Weight1.41%
1M Return1.28%
Value99.92
Score2/3
Weight1.41%
1M Return1.28%
Is DNA undervalued or overvalued?
- DNA scores 7.09/10 on fundamentals and holds a Discounted valuation at present. Backed by its -36.37% ROE, -188.00% net margin, -1.94 P/E ratio, 1.09 P/B ratio, and 51.94% earnings growth, these metrics solidify its Outperform investment rating.
